Skip to content
Recall Observatory FDA recall evidence

Drug product

Cefixime for Oral Suspension USP 200 mg/5 mL (50 mL Pack size), Powder for oral suspension, Rx only, Manufactured for: Lupin Pharmaceuticals, Inc., Baltimore Maryland, Manufactured by: Lupin Limited, Mandideep, India NDC 68180-407-03

D-0559-2024

May 30, 2024

Class II

Product summary

Firm
Lupin Pharmaceuticals Inc.
Event
Event 94723
Status
Terminated
Classification
Class II
Quantity
3,552 bottles
Official record key
drug-enforcement:D-0559-2024

Official wording

Reason: Failed Content Uniformity Specifications

Code information: Lot F201519, Expiry: November 2024

Distribution pattern: Nationwide in the US

Derived failure modes

  • Potency or specification failure

    reason.potency_specification_failure · v1.0.0

    Failed Content Uniformity Specifications